IP Library Granted Patent US 7,384,916
Granted Patent B2
US 7,384,916 · App. 11/376,728 · Granted Jun 10, 2008

Methods and compositions for preventing and treating aging or photodamaged skin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,384,916
App. No.
11/376,728
Granted
Jun 10, 2008
Kind
B2
Abstract

Disclosed are methods for treating aging and photodamaged skin employing topical application of compositions which comprise at least one peptide manganese complex. Also disclosed are methods wherein the composition further comprises retinol, at least one retinol derivative, or a mixture thereof and methods wherein the composition further comprises active agents selected from active drug substances, emollients, sunscreen agents, skin lightening agents, skin protectants, skin conditioning agents, humectants, and mixtures thereof.

Claims (17)

1. A method for treating photodamaged skin comprising contacting an area of skin in need thereof with an effective amount of a composition, wherein the composition comprises at least one peptide manganese complex selected from the group consisting of L-alanyl-L-histidyl-L-lysine:manganese(II) and L-valyl-L-histidyl-L-lysine:manganese(II).

2. The method of claim 1 wherein the at least one peptide manganese complex comprises L-alanyl-L-histidyl-L-lysine:manganese(II).

3. The method of claim 1 wherein the at least one peptide manganese complex comprises L-valyl-L-histidyl-L-lysine:manganese(II).

4. The method of claim 1 wherein the molar ratio of peptide to manganese in the at least one peptide manganese complex ranges from about 1:1 to about 3:1.

5. The method of claim 4 wherein the molar ratio of peptide to manganese in the at least one peptide manganese complex ranges from about 1:1 to about 2:1.

6. The method of claim 1 wherein the at least one peptide manganese complex is present at a concentration ranging from about 0.01% to about 5% by weight of the composition.

7. The method of claim 6 wherein the at least one peptide manganese complex is present at a concentration ranging from about 0.025% to about 1% by weight of the composition.

8. The method of claim 7 wherein the at least one peptide manganese complex is present at a concentration ranging from about 0.05% to about 0.5% by weight of the composition.

9. The method of claim 1 wherein the at least one peptide manganese complex is encapsulated in a liposome, microsponge or polymer matrix adapted to aid in the delivery of the peptide manganese complex to the area of skin or to enhance the stability of the composition.

10. The method of claim 1 wherein the at least one peptide manganese complex is formulated in an instrument adapted to deliver the peptide manganese complex to the area of skin via iontophoresis.

11. The method of claim 1 wherein the composition further comprises an inert and physiologically-acceptable carrier or diluent.

12. The method of claim 11 wherein the inert and physiologically-acceptable carrier or diluent is water, physiological saline, bacteriostatic saline, a petrolatum based cream, a pharmaceutically acceptable gel, a short chain alcohol, or a short chain glycol.

13. The method of claim 1 wherein the composition further comprises a skin lightening agent, a sunscreen agent, a skin conditioning agent, a skin protectant, an emollient, a humectant, or a mixture thereof.

14. The method of claim 1 wherein the composition further comprises a fatty alcohol, a fatty acid, an organic base, an inorganic base, a preserving agent, a wax ester, a steroid alcohol, a triglyceride ester, a phospholipid, a polyhydric alcohol ester, a fatty alcohol ether, a hydrophilic lanolin derivative, a hydrophilic beeswax derivative, a cocoa butter wax, a silicon oil, a pH balancer, a cellulose derivative, a hydrocarbon oil, or a mixture thereof.

15. The method of claim 1 wherein the composition further comprises an emulsifying agent, a surfactant, a thickening agent, an excipient, or a mixture thereof.

16. The method of claim 1 wherein the composition is in the form of a solution, cream, gel, fluid cream, lotion, or oil.

17. The method of claim 1 wherein the composition further comprises retinol, a retinol derivative, or a mixture thereof.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jun 23, 2015
From: JPMORGAN CHASE BANK, N.A.
To: PHOTOMEDEX, INC.; GATORADE ACQUISITION CORP.; RADIANCY, INC.; PHOTOMEDEX TECHNOLOGY, INC.; LUMIERE, INC.
Reel/Frame 036007/0222 →
SECURITY INTEREST Recorded May 14, 2014
From: PHOTOMEDEX, INC.; GATORADE ACQUISITION CORP.; RADIANCY, INC.; PHOTOMEDEX TECHNOLOGY, INC.; LUMIERE, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 032892/0586 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Dec 13, 2011
From: PERSEUS PARTNERS VII, L.P.
To: PHOTOMEDEX, INC.; PROCYTE CORPORATION; PHOTO THERAPEUTICS, INC.; SLT TECHNOLOGIES, INC.
Reel/Frame 027374/0134 →
SECURITY AGREEMENT Recorded Apr 16, 2010
From: PHOTOMEDEX, INC.; PROCYTE CORPORATION; PHOTO THERAPEUTICS, INC.; SLT TECHNOLOGY, INC.
To: PERSEUS PARTNERS VII, L.P.
Reel/Frame 024244/0480 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2006
From: PATT, LEONARD M.
To: PROCYTE CORPORATION
Reel/Frame 017829/0167 →